ACTA POLONIAE PHARMACEUTICA – DRUG RESEARCH
Aims and scope
The international journal of the Polish Pharmaceutical Society is published in 6 issues a year. The journal offers Open Access publication of original research papers, short communications and reviews written in English, in all areas of pharmaceutical sciences.
Aims: The aim of Acta Poloniae Pharmaceutica is to present both Polish and global scientific achievements in pharmaceutical sciences. The journal also focuses on raising important topics in pharmaceutical legislation to encourage greater integration of the Polish and foreign pharmaceutical environments.
Scope: The Acta Poloniae Pharmaceutica – Drug Research includes experimental scientific and review articles that cover advancements in pharmaceutical sciences, including applied pharmacy, drug formulation technology, pharmacoepidemiology, pharmacognosy, pharmacoeconomics, toxicology, and social pharmacy. These topics are organized into several sections: analysis, biopharmacy, drug biochemistry, drug synthesis, natural drugs, pharmacology, pharmaceutical technology, food and nutrition, and general (review).
A bimonthly appearing in English since 1994, which continues “Acta Poloniae Pharmaceutica”, whose first issue appeared in December 1937. The war halted the activity of the journal’s creators. Issuance of “Acta Poloniae Pharmaceutica” was resumed in 1947. From 1947 the journal appeared irregularly, initially as a quarterly, then a bimonthly. In the years 1963–1973 alongside the Polish version appeared the English edition of the journal. Starting from 1974 only works in English are published in the journal. Since 1995 the journal has been appearing very regularly in two-month intervals (six books a year). The journal publishes original works from all fields of pharmacy, summaries of postdoctoral dissertations and laboratory notes.
In the years 2022-2024, the scientific journal "Acta Poloniae Pharmaceutica - Drug Research accomplishes a project no. RCN/SN/0552/2021/1, financed from the Ministry of Education and Science (Poland) in the framework of a program “Development of scientific journals”
Table of contents
| Full list of numbers – see the whole list |  |
 |
Articles are available in open access, licensed under CC BY NC https://creativecommons.org/licenses/by-nc/4.0/
Manuscript submission
Editorial System is an online submission and review system. Authors must submit their manuscripts and track their progress through the system. In order to access the Editorial System, please submit your manuscript at:
In accordance with the announcement the Polish Ministry of Education and Science of December 1, 2021 on The list of scientific journals and reviewed materials from international conferencesof the number of points for publishing a scientific article in "Acta Poloniae Pharmaceutica - Drug Research" to 100 points was increased. The editorial team of encourages all reviewers to continue cooperation and authors to article publication in journal.
Link to the full list below:
According to the Ordinance of the Minister of Health of the 28th December 2021 on educational points obtained as part of continuous professional development and the model of a pharmacist's professional development card, a pharmacist may obtain educational points for an individual subscription to a scientific journal in the field of medical sciences and health sciences. We encourage pharmacists to subscribe individually to "Acta Poloniae Pharmaceutica - Drug Research".
Information on the number of points for an individual subscription can be found in Annex 2 (No. 26) to the ordinance of the Minister of Health of the 28th December 2021 (Dz. U. 2021, No. 2494).
Regulation - download file
IMPORTANT INFORMATION
Open Access Publication Fee since September 1, 2023
All articles published in Acta Poloniae Pharmaceutica – Drug Research (ISSN ) are published in full open access. In order to provide free access to readers, and to cover the costs of peer review, copyediting, typesetting, long-term archiving, and journal management, an article processing charge (APC) of 3900 PLN (Polish Zloty) + 8% VAT or 950 EUR (EUROS) applies to papers accepted after peer review.
Accepted Currencies
We accept payments in Polish Zloty (PLN) and Euros (EUR), US Dollars (USD). Upon acceptance, the corresponding author will receive an e-mail with a link where the currency of the invoice can be changed.
Accepted Methods of Payment
Polish Pharmaceutical Society currently supports the following payment methods:
- Bank Transfer in Polish Zloty (PLN) for Polish authors (3900 PLN + 8% VAT ); Fee since September 1, 2023 (4120 PLN + 8% VAT)
- Bank Transfer in Euros (EUR) for Foreign authors (950 EUR); Fee since September 1, 2023 (950 EUR)
BANK ACCOUNT
1. SWIFT Address: BANK MILLENNIUM SA, 02-593 WARSZAWA, POLAND, STANISŁAWA ŻARYNA 2A St.
2.. SWIFT CODE: BIGBPLPWXXX
3. International Beneficiary Account Number/IBAN: PL 30 1160 2202 0000 0000 2777 0200
4. Bank Name BANK MILLENNIUM SA